Biologix Hair, Inc. signed a letter of intent to acquire T&G Apothecary Inc. (OTCBB:TGPO) in a reverse merger transaction on September 21, 2012. As per the terms of the letter of intent, T&G Apothecary would acquire all the outstanding shares of Biologix Hair in exchange for 26.43 million of its outstanding shares, post a forward spilt of 7:1 ratio and pay $0.3 million as a non refundable fee to Biologix as an additional consideration. The business combination contemplated by the letter of intent is subject to the fulfillment of certain conditions precedent; including but not limited to the due diligence, the negotiation of a definitive agreement, approval of T&G Apothecary's and Biologix's Board of Directors and shareholders of Biologix, the completion of an audit of the Biologix financial statements, completion of private placement, the outstanding shares of Biologix should not be more than 26.43 million, forward split, cancellation of shares, the outstanding shares of T&G should not be more than 56.63 million, the outstanding liabilities of T&G should not be more than $0.1 million and customary third party and regulatory approvals.

As on November 23, 2012, T&G Apothecary entered into a share purchase agreement with Biologix Hair, Inc. In anticipation of the proposed acquisition, T&G Apothecary submitted proposal for the change of its name to “Biologix Hair Inc”. On closing, Ronald Holland, Chairman and Chief Executive Officer of Biologix Hair would be appointed as a member and Chairman of the Board of Directors of T&G Apothecary.